Early diagnosis and treatment of generalized myasthenia gravis (MG) are important to achieve symptomatic control and limit ...

Background Long-term immunosuppressive treatment does not efficiently prevent relapses of lupus nephritis (LN). This investigator-initiated randomised trial tested whether mycophenolate mofetil (MMF) ...

Belimumab, a monoclonal antibody, added to standard therapy may treat a broader range of patients with lupus nephritis than previously appreciated.

The EULAR updated their recommendations for antirheumatic drug use among patients with RMDs during pregnancy and fertility ...

To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

Tegoprubart and mycophenolate mofetil (MMF) were given as the immunosuppressant therapy in the study, every third week by intravenous infusion, with the first two subjects achieving insulin ...

When the problem is due to active lupus (flaring), the disease is treated with glucocorticoids (such as prednisone) and immunosuppressive drugs (such as cyclophosphamide, mycophenolate mofetil, ...

For Sjogren’s that is systemic, a steroid such as prednisone can be used effectively, as can conventional immunosuppressive agents like methotrexate and mycophenolate, TNF Alpha inhibitors and the ...